Abstract:
Objective. To investigate whether assessment of C-reactive protein (CRP) and apolipoproteins, besides the traditional lipid profile,
enhances the assessment process for the risk of acute coronary syndrome (ACS). Methods. The study group consisted of 220
consecutive patients admitted to hospital within the first 6 hours from the onset of chest pain. Patients were diagnosed with
unstable angina (n = 96), non-ST-elevation myocardial infarction (NSTEMI; n = 57), or ST-elevation myocardial infarction
(STEMI; n = 67). ACS patients were compared with 116 healthy volunteers in a case-control study. The serum was assayed on
admission for CRP, apolipoproteins ApoAI and ApoB100, and lipid parameters. Results. The highest concentrations of CRP were
found in NSTEMI and STEMI, with a median value four-fold higher in ACS patients than in controls (P < 0.0001). Only CRP
significantly increased the probability of ACS development (adjusted odds ratio for a 1 mg/L increase 1.90; 95% confidence interval
[CI] 1.34–2.89) and explained 90% of the variation for ACS development. Similarly, we demonstrated the highest diagnostic
accuracy for CRP among all investigated markers (area under the curve 0.80; 95% CI 0.75–0.85). Conclusions. Our study indicates
that CRP superiorly to apolipoproteins and lipid profile facilitates the risk stratification for ACS occurrence.
